This proposal is supported by various transgenic mouse studies in which SCN5A was mutated to recapitulate loss-of-function SCN5A channelopathy exhibited age-dependent degenerative histopathologic changes, including fibrosis and fatty replacement [23]–[24]. The gene discussed is SCN5A; the disease is channelopathy.